DoW Tuberous Sclerosis Complex, Clinical Translational Research Award

The Department of the Army -- USAMRAA is soliciting applications for the Tuberous Sclerosis Complex Research Program (TSCRP) Clinical Translational Research Award (CTRA). This funding mechanism supports studies that will move promising, well-founded preclinical and/or clinical research findings closer to clinical application, including diagnosis, prognosis, or treatment of tuberous sclerosis complex (TSC). Key features of this opportunity include: • The ability for multiple Principal Investigators (PIs) to collaborate on a research project • The requirement for only the initiating PI to submit a pre-application, while all PIs will need to submit full applications • An estimated funding amount of $3,500,000, with an expected 2 awards to be made • An application deadline of August 6, 2026